Bio

Medical doctor, researcher and author with a deep expertise in aging/longevity and new trends, developments and paradigm shifts in medicine - which new technologies will disrupt medicine, health(care) and our lifespan? How will the current new industrial revolution transform medicine? Main medical focus on aging (biogerontology), metabolism (diabetes, cardiovascular disease, neurodegenerative diseases, obesity), and neuroscience. Biotechnological focus on novel methods for gene editing, transcriptomics, epigenetics, AI, drug discovery, etc. Venture Partner at the Longevity Vision Fund, a $100 million fund that invests in (bio)technologies to slow down aging. Co-founder of NOVOS, the first science-based nutraceutical to address 9 important hallmarks of aging. Wrote his first science book at the age of 16 and 4 books by the age of 28. One 520-page book uses scientific insights from biology, physics, mathematics and chemistry to addresses philosophical questions. His most recent book ''The Longevity Code'' explains how nutrition and new biotechnologies can slow down aging and improve health. “Dr. Verburgh tackles age-old questions and arrives at some startling conclusions – with practical suggestions for how to slow down our biological clock.” - Professor David Ludwig, Harvard University and Harvard Medical School, about ''The Longevity Code'' Expertise and interests: • New trends and developments in medicine, biotechnology and healthcare • Biogerontology/aging (new biotechnologies, nutrition and nutraceuticals to slow down aging - created a new field called ''nutrigerontology'' (Aging Cell, 2014)) • Preventive, personalized and predictive medicine and general health • Neuroscience, including neuroesthetics, origins of creativity and intelligence, neurobiological roots of morality and religion (university master dissertation).